GVK BIO Announces Appointment of Robert R. Ruffolo, Ph.D., to its Board of Directors
HYDERABAD, India–(BUSINESS WIRE)–#ContractResearchandDevelopment–GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of…
Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India–(BUSINESS WIRE)–#ContractResearchandDevelopment–GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of…
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has submitted a Biologics License Application (BLA) to the U.S.…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) announced today an update relative to the Company’s…
‒ Plan expected to reduce costs by approximately $50 million annually ‒ ‒ Reduces Full Year 2019 Adjusted EBITDA Guidance…
Data Include Week 48 Results from Phase 2B Study Evaluating MK-8591 in Combination with Doravirine KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:…
LONDON–(BUSINESS WIRE)–#Biotechnology–Vendors in the cancer biologics market have significantly increased investments for the development of cancer treating biologic molecules. Consequently,…
— Company to establish new subsidiary office in Liege, Belgium — LYON, France–(BUSINESS WIRE)–Osivax announced today that it has secured…
LONDON–(BUSINESS WIRE)–#Biotechnology–The advantages of modified versions over conventional dosage forms are encouraging several companies to focus on developing modified versions…
TOKYO–(BUSINESS WIRE)–#CRO–CMIC Group, a pioneer and a leading CRO (Contract Research Organizations) in Japan, is pleased to announce that the…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will announce its second-quarter 2019 financial results before…